Sources

11 Total Sources

Johnson & Johnson Drops 2.7% as 3.6% MedTech Growth Undercuts Raised Outlook

Center100%

Johnson & Johnson (JNJ) Stock Drops 2.7% on MedTech Underperformance

Stocks steady as oil surge offsets ASML lift to tech

Why Johnson & Johnson Stock Slipped Despite Earnings Beat | EBC Financial Group

finance.biggo.com22h ago

J&J Raises 2026 Outlook as Tremfya, Darzalex Fuel Q2 Beat Despite Stelara, Abiomed Headwinds — BigGo Finance

intellectia.ai22h ago

Johnson & Johnson's Strong Earnings Fail to Boost Stock Price | Intellectia.AI

tickeron.com22h ago

Stryker Corporation (SYK): Unpacking the -10% Decline and Path Forward

Investing.com22h ago

Why Johnson & Johnson's Earnings Dip Looks Like a Buying Opportunity | Investing.com

MarketBeat22h ago

JNJ Stock Pulls Back After Earnings, Setting Up a Buying Opportunity

24/7 Wall St.22h ago

Will Johnson & Johnson Stock Hit $300 This Year? - 24/7 Wall St.

Yahoo Finance22h ago

Johnson & Johnson (JNJ) Stock Price, News, Quote & History - Yahoo Finance

Instagram22h ago

Johnson & ⁠Johnson beat Wall Street estimates for second-quarter sales and profit on Wednesday and also increased its full-year sales and ⁠profit ‌forecast. Read more at the link in bio.